About FlyNew
Who are we
FlyNew Bio Inc is a transformative biotech global company. We tap into innovation and technology to develop patented pharmaceuticals and breakthrough treatment plans that benefit humankind.
Currently we have labs in America and China working together to accelerate the process of developing targeted patents in several medical fields patents for Acute Myeloid Leukemia (AML), Triple-Negative Breast Cancer (TNBC), Alcoholic Liver Disease (ALD), Nephritis, Alzheimer’s disease, Cardiovascular disease etc. With multiple pharmaceutical patents in place and eight more in progress, we are on our way to developing solutions people around the world can benefit from.
OUR LEADERSHIP
Meet Our Leadership Team
Our leadership team drives transformative innovation with a blend of deep industry expertise and strategic foresight. Their genuine passion shapes our journey toward groundbreaking advances in healthcare, positioning FlyNew Bio Inc. as a global pioneer in pharmaceutical innovation.
FlyNew Partnership
Harvard University
Chinese Academy of Sciences
California State University, Fresno
UCLA Jonsson Comprehensive Cancer Center
University of Pittsburgh
China Pharmaceutical University
David Geffen UCLA School of Medicine
National Cancer Institute